Efficacy of DTaP, Tdap Holds Despite Pertactin Deficiency
Similar estimates for DTaP, Tdap VE to other settings, despite high prevalence of pertactin deficiency
ASCO Presents Guidelines for Increasing HPV Vaccine Uptake
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
CV Risk Not Significantly Different for GLP-1 Receptor Agonists
Findings based on large study in real-world, head-to-head comparison of other drugs
Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation
Many believe meds supported by stronger evidence than the law requires to achieve designation
USPSTF: Aspirin Recommended for Some Aged 50 to 69 Years
Benefits for primary prevention of CVD, CRC for certain adults aged 50 to 69 years
FDA Approves Venclexta for CLL With 17p Deletion
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
Exenatide Twice Daily Deemed Efficacious Across BMI Ranges
Significant weight loss with exenatide across BMI ranges; weight increased with comparators
Progesterone Attenuates Drug-Induced QT Interval Lengthening
Findings in healthy females who received progesterone or placebo for seven days
VA Commission on Care: Eliminate VA Medical Centers
Eight veterans organizations denounce document in letter to Commission Chairwoman
Guidance Issued on Use of Direct Oral Anticoagulants in Obese
DOAC use not recommended for patients with BMI >40 kg/m² and weight >120 kg
